TS-075845 — Drug discovery, biologics development, cell therapy research, and advanced in vitro testing all rely on large numbers of cell-based experiments. While continuous perfusion can improve biological relevance by maintaining nutrient availability, removing waste products, and better mimicking physiolog…

TS-075637 — Microfluidic and organ-on-chip platforms are gaining importance in drug discovery, toxicity testing, diagnostics, and advanced biological research. However, widespread adoption remains constrained by the difficulty of connecting microscale devices to conventional fluid delivery hardware. Existing …

TS-073289 — Understanding how cells respond to soluble signals under diffusion-limited conditions remains a significant gap in current in vitro models. Most microfluidic systems rely on convective flow, which does not accurately reflect transport in interstitial tissue or solid tumors, where diffusion dominat…

TS-071982 — The Need Current microfluidic systems for long-term perfusion rely heavily on syringe or peristaltic pumps, which are costly, bulky, and require external power and technical expertise. These limitations hinder scalability, accessibility, and usability, especially in resource-limited settings. There …

TS-051995 — Method of regenerating NADPH for the production of biobutanol.

TS-038384 — A novel device for monitoring cancer cell motility in real time using standard microscopy.